"Note: There are currently zero future large indications...

"Note: There are currently zero future large indications approved. I.e. There currently is no problem to be solved."

This is what you posted. You said there is nothing approved therefore there is no problem to solve. This is an insane opinion to have on a biotech company. You are saying that you don't invest based on the future, only the present. If so, why have you been in MSB for years? It's been a cash furnace since inception - you were investing on the future, which has eventually played out in a small way (at a >$1B cost to shareholders).

SI would never, IMO, consider a CYP takeover. That would essentially render his life's work pointless, and that guy clearly has too much of an ego to pivot like that. So there is no need for KK to persuade SI. There is a need for KK to persuade investors, and yes that includes you and I as retail investors, of the benefits of Cynata's platform technology and business model. Releases like today help. A commercial deal for one of the indications would be even more compelling. But partnering GvHD now would be irresponsible as it will be worth more once the results are released (assuming they are good).

""development of ‘3D’ has been anaemic". What does that even mean?I assume you are inferring it hasn't happened? Yeah, that's right. Horse before the cart. The last Mesoblast CR nominated funds to manufacturing - I assume that is 3D."

You understand exactly what is wrong with SI: He is all talk and little action. 3D has been "under development" for nearly a decade according to the annual reports, but it's about as far away from reality as it was last year or the year before that, etc.